期刊文献+

辐射诱导人TRAIL基因表达的腺病毒穿梭质粒的构建及鉴定 被引量:2

Construction and identification of recombinant adenoviral shuttle vector with radiation-inducible TRAIL gene
下载PDF
导出
摘要 目的:构建辐射敏感Egr-1启动子诱导人肿瘤坏死因子(TNF)相关凋亡诱导配体(TRAIL)基因表达的腺病毒穿梭质粒pshuttle-Egr1-hTRAIL。方法:利用逆转录-聚合酶链式反应(RT-PCR)方法从pACCMV-hTRAIL质粒中扩增得到TRAIL基因片段,并将其连接到pMD19T载体进行测序,利用基因重组技术构建含有辐射诱导启动子Egr-1的腺病毒穿梭质粒pshuttle-Egr1-hTRAIL。结果:PCR扩增出约820 bp的片段,测序结果证实扩增片段的序列与GenBank公布(NM_003810)的一致。pshuttle-Egr1-hTRAIL用EcoRⅠ、KpnⅠ双酶切重组得到大小为3 540和4 299 bp的2个片段,用SmaⅠ酶切得到1 517、2 282和4 040 bp的3个片段,用BamHⅠ酶切得到3 304和4 535 bp的2个片段,与预期结果完全一致。结论:成功克隆了hTRAIL基因,并构建了辐射诱导表达的腺病毒穿梭质粒pshuttle-Egr1-hTRAIL。 Objective To construct a recombinant adenoviral shuttle vector pshuttle-Egrl-hTRAIL containing radiation-sensitive Egr-1 promoter and TNF-related apoptosis-inducing ligand (TRAIL). Methods The TRAIL gene fragment was acquired from the plasmid pACCMV-hTRAIL by RT-PCR. Then the TRAIL gene was ligated to pMD19T vector and sequenced. With the gene recombinant technique, the recombinant plasmid pshuttle-Egrl- hTRAIL with radiation-inducible promoter Egr-1 was constructed. Results A fragment about 820 bp was amplified by PCR, and the sequence of acquired bTRAIL gene was totally in concordance with that published in GenBank (NM_003810). Moreover, the recombinant plasmid pshuttle-Egrl-hTRAIL was digested by EcoR I and Kpn I double-enzyme and BamH I singly both into two fragments, with the length of 3 540 and 4 299 bp, 3 304 and 4 535 bp, respectively. The Sma I enzyme could digest it into three fragments with lengths of 1 517, 2 282 and 4 040 bp. The results of enzyme identification were all in concordance with that expected. Conclusion The hTRAIL gene is cloned and the recombinant plasmid pshuttle-Egrl-hTRAIL is constructed successfully.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2008年第3期364-368,共5页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(30570546)
关键词 TRAIL 克隆 分子 腺病毒 辐射 EGR-1 TRAIL cloning, molecular adenovirus radiation Egr-1
  • 相关文献

参考文献11

  • 1Weichselbaum RR, Hallahan DE, Beckett MA, et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells [J]. Cancer Res, 1994, 54 (16):4266-4269.
  • 2Weichselbaum RR, Hallahan DE, Sukhatme VP, et al. Gene therapy targeting by ionizing radiation [J]. Int J Radiat Oncol Biol Phys, 1992, 24 (3):565-567.
  • 3Hallahan DE, Mauceri HJ, Seung LP, et al. Spatial and temporal control of gene therapy using ionizing radiation [J]. Nat Med, 1995, 1 (8): 786-791.
  • 4Hsu H, Rainov NG, Quinones A, et al. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter [J]. Anticancer Res, 2003, 23 (3B):2723- 2728.
  • 5Weichselbaum RR, Kufe DW, Hellman S, et al. Radiationinduced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy [J]. Lancet Oncol, 2002, 3 (11): 665-671.
  • 6Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of new membe of the TNF family that induces apoptosis [J]. Immunity, 1995, 3 (6) : 673-682.
  • 7Wissink EH, Verbrugge I, Vink SR, et al. TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy [J]. Radiother Oncol, 2006, 80 (2) 224-222.
  • 8Baierlein SA, Distel L, Sieber R, et al. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells [J]. Strahlenther Onkol, 2006, 282 (8):467-472.
  • 9Tsurushima H, Yuan X, Dillehay LE, et al. Radioresponsive tumor necrosis factor-related apoptosis-inducing llgand (TRAIL) gene therapy for malignant brain tumors [J]. Cancer Gene Ther, 2007, 14 (8) : 706-716.
  • 10Matsubara H, Mizutani Y, Hongo F, et al. Gene therapy with TRAIL against renal cell carcinoma [J]. Mol Cancer Ther, 2006, 5 (9);2165-2171.

同被引文献13

  • 1YANGWei LIXiu-yi.Anti-tumor effect of pEgr-interferon-γ-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism[J].Chinese Medical Journal,2005(4):296-301. 被引量:20
  • 2Weichselbaum RR,Kufe DW,Advani SJ,et al.Molecular targeting of gene therapy and radiotherapy[J].Acta Oncol,2001;40(6):735.
  • 3Hsu H,Rainov NG,Quinones A,et al.Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter[J]. Anticancer Res,2003;23(3B):2723-8.
  • 4Weichselbaum RR,Kufe DW,Hellman S,et al.Radiation induced tumour necrosis factor-alpha expression:clinical application of transcriptional and physical targeting of gene therapy[J].Lancet Oncol,2002;3(11):665-71.
  • 5Harrison L,Blackwell K.Hypoxia and anemia:factors in decreased sensitivity to radiation therapy and chemotherapy〔J〕?Oncologist,2004;9(Suppl 5):31-40.
  • 6Kaluz S,Kaluzová M,Stanbridge EJ.Regulation of gene expression by hypoxia:Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element [J].Clin Chim Acta,2008;395:6-13.
  • 7Greco O,Marples B,Dachs GU,et al.Novel chimeric gene promoters responsive to hypoxia and ionizing radiation〔J〕.Gene Ther,2002;9(20):1403-11.
  • 8Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of new member of the TNF family that induces apoptosis[J].Immunity,1995;3(6):673-82.
  • 9Wendt J,von Haefen C,Hemmati P,et al.TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway[J].Oncogene,2005;24(25):4052-64.
  • 10Tsurushima H,Yuan X,Dillehay LE,et al.Radioresponsive tumor necrosis factor related apoptosis inducing ligand (TRAIL ) gene therapy for malignant brain tumors[J].Cancer Gene Ther,2007;14(8):706-16.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部